Christopher Gerard is COO at AMEDISYS INC (AMED). They have made 15 open-market trades across 1 company since 2018, most recently 2022-02-20.
CIK 0001694097
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMED | 43,965 | $4.4M |
Shares reported on the most recent Form 4, priced at the 2022-02-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMED | SELL | 2021-08-02 | 2021-08-04 | $261.23 | $575K | -10.6% | -10.6% | -15.4% |
| AMED | SELL | 2021-07-01 | 2021-07-06 | $250.90 | $314K | -4.4% | -25.9% | -47.1% |
| AMED | SELL | 2021-06-01 | 2021-06-03 | $256.81 | $514K | -1.1% | +8.0% | -26.3% |
| AMED | SELL | 2021-05-25 | 2021-05-27 | $259.64 | $597K | -0.7% | -3.2% | -31.6% |
| AMED | SELL | 2021-01-15 | 2021-01-20 | $289.77 | $283K | -6.1% | -4.4% | -8.1% |
| AMED | SELL | 2020-12-15 | 2020-12-17 | $272.87 | $330K | +1.6% | +4.8% | -5.1% |
| AMED | SELL · 10b5-1 | 2020-11-16 | 2020-11-18 | $243.68 | $183K | +2.5% | +19.6% | +23.0% |
| AMED | SELL | 2020-10-15 | 2020-10-19 | $252.03 | $378K | +1.9% | -1.7% | +21.1% |
| AMED | SELL | 2020-09-15 | 2020-09-17 | $239.23 | $681K | -2.3% | +3.6% | +14.2% |
| AMED | SELL | 2020-08-03 | 2020-08-05 | $231.40 | $312K | +0.3% | -0.5% | +11.8% |
| AMED | SELL · 10b5-1 | 2020-07-01 | 2020-07-06 | $203.43 | $153K | +2.3% | +13.4% | +16.7% |
| AMED | SELL | 2020-06-01 | 2020-06-03 | $189.32 | $236K | -1.8% | +16.0% | +34.9% |
| AMED | SELL | 2020-05-01 | 2020-05-05 | $182.27 | $205K | +3.3% | -1.4% | +29.4% |
| AMED | SELL · 10b5-1 | 2020-04-01 | 2020-04-03 | $178.13 | $134K | +17.7% | -3.9% | +12.4% |
| AMED | SELL · 10b5-1 | 2020-03-09 | 2020-03-11 | $165.69 | $124K | +6.1% | +23.9% | +11.4% |
| AMED | SELL · 10b5-1 | 2020-02-03 | 2020-02-05 | $178.98 | $63K | +8.4% | -6.5% | -4.7% |
| AMED | SELL · 10b5-1 | 2020-01-02 | 2020-01-06 | $165.22 | $58K | +8.3% | +11.3% | +10.1% |
| AMED | SELL | 2019-12-02 | 2019-12-04 | $162.97 | $57K | -3.5% | +0.3% | +0.8% |
| AMED | SELL · 10b5-1 | 2019-11-01 | 2019-11-05 | $145.15 | $51K | +4.5% | +13.1% | +22.5% |
| AMED | SELL | 2019-10-01 | 2019-10-03 | $128.79 | $45K | +6.2% | +18.2% | +33.2% |
| AMED | SELL · 10b5-1 | 2019-09-09 | 2019-09-11 | $134.79 | $47K | +0.7% | -3.8% | +23.5% |
| AMED | SELL | 2019-03-11 | 2019-03-13 | $118.96 | $297K | +1.0% | +3.0% | -4.1% |
| AMED | SELL | 2018-11-09 | 2018-11-14 | $119.23 | $1.2M | +5.6% | +6.0% | +15.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.